Free Trial

Sunshine Biopharma (SBFM) Earnings Date, Estimates & Call Transcripts

Sunshine Biopharma logo
$1.50 +0.02 (+1.35%)
Closing price 09/12/2025 03:57 PM Eastern
Extended Trading
$1.47 -0.03 (-2.00%)
As of 09/12/2025 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sunshine Biopharma Earnings Summary

Sunshine Biopharma released Q2 2025 earnings on August 12, 2025, reporting an EPS of -$0.39, which missed analysts' consensus estimates of -$0.11 by $0.28. Quarterly revenue was reported to be $9.41 million, below analysts' expectations of $12.10 million. Sunshine Biopharma currently has a trailing EPS of -$150.88

Q2 2025 Earnings Resources

SBFM Upcoming Earnings

Sunshine Biopharma's next earnings date is estimated for Tuesday, November 4, 2025, based on past reporting schedules.

Upcoming Q3
Earnings Date
Nov. 4Before Market OpensEstimated
Consensus EPS
(Aug. 12)
-$0.11
Actual EPS
(Aug. 12)
-$0.39 Missed By -$0.28
Actual Revenue
(Aug. 12)
$9.41M
Get Sunshine Biopharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sunshine Biopharma and other key companies, straight to your inbox.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

SBFM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SBFM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Sunshine Biopharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/4/2025
(Estimated)
--------
8/12/2025Q2 2025-$0.11-$0.39 -$0.28-$0.39$12.10M$9.41M
5/15/2025Q1 2025--$0.44--$0.44-$8.90M
11/5/2024-$9.00-$0.94 -$9.94-$0.94-$8.44M
8/16/2024Q2 2024--$9.94--$9.94-$9.30M
5/20/2024Q1 2024--$2.00--$2.00-$7.54M
3/28/2024Q4 2023--$5.00--$5.00-$7.68M
11/13/2023Q3 2023-$6.00-$4.00+$2.00-$0.04-$5.96M


This page (NASDAQ:SBFM) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners